Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study

BACKGROUND: Bisphosphonates are the first-line therapy for the treatment of osteoporosis. In the province of Ontario, the Ontario Drug Benefit Program funds medications for patients aged 65 years and older. The Ontario Drug Benefit Program has a generic substitution policy that requires lower-cost g...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:CMAJ Open
Asıl Yazarlar: Fraser, Lisa-Ann, Albaum, Jordan M., Tadrous, Mina, Burden, Andrea M., Shariff, Salimah Z., Cadarette, Suzanne M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 8872147 Canada Inc. 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382038/
https://ncbi.nlm.nih.gov/pubmed/25844376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.2014-0090
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller